Preclinical toxicity of DATR, a recombinant soluble human TRAIL mutant, in rats and cynomolgus monkeys

► DATR is a promising agent for cancer therapy. ► The toxicity of DATR was reversible and did not differ from that associated TRAIL. ► The target toxic organs of DATR may be the haematological system, kidney and liver.